Preclinical studies with amphotericin B lipid complex

Drugs of Today

Volumn 32, Issue SUPPL. G, 1996, Pages 1-7

  Swenson, Christine E ^a   Janoff, Andrew S ^a  

^a Liposome Company Incorporated   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B DERIVATIVE; AMPHOTERICIN B LIPID COMPLEX;

ANIMAL EXPERIMENT; ANTIFUNGAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ASPERGILLUS; CANDIDA ALBICANS; COMPLEX FORMATION; CRYPTOCOCCUS NEOFORMANS; IN VITRO STUDY; IN VIVO STUDY; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; NONHUMAN; RAT; REVIEW;

EID: 0029805532     PISSN: 16993993     EISSN: 16994019     Source Type: Journal    
DOI: None     Document Type: Review

References (24)

1. Janoff, A.S., Boni, L.T., Popescu, M.C. et al. Unusual lipid structures selectively reduce the toxicity of amphotericin B. Proc Natl Acad Sci USA 1988, 85: 6122-6.
2. Perkins, W.R., Minchey, S.R., Boni, L.T. et al. Amphotericin B-phospholipid interactions responsible for reduced mammalian cell toxicity. Biochim Biophys Acta 1992, 1107: 271-82.
3. ®): A molecular rationale for the attenuation of amphotericin B related toxicities. J Liposome Res 1993, 3: 451-71.
4. De Kruijff, B., Demel, R.A. Polyene antibiotic-sterol interactions in membranes of Acholeplasma laidlawi cells and lecithin liposomes III. Molecular structure of the polyene antibiotic-cholesterol complexes. Biochim Biophys Acta 1974, 339: 57-70.
5. Data on file, The Liposome Company, Inc.
6. Kotler-Brajtburg, J., Medoff, G., Kobayashi, G.S. Classification of polyene antibiotics according to chemical structure and biologic effects. Antimicrob Agents Chemother 1979, 15: 716-22.
7. Mehta, R., López-Berestein, G., Hopfer, R., Mills, K., Juliano, R. Liposomal amphotericin B is toxic to fungal cells but not to mammalian cells. Biochim Biophys Acta 1984, 770: 230-4.
8. Jullien, S., Contrepois, A., Sligh, J.E. et al. Study of the effects of liposomal amphotericin B on Candida albicans, Cryptococcus neoformans and erythrocytes by using small unilamellar vesicles prepared from saturated phospholipids. Antimicrob Agents Chemother 1989, 33: 345-9.
9. Clark, J.M., Whitney, R.R., Olsen, S.J. et al. Amphotericin B lipid complex therapy of experimental fungal infections in mice. Antimicrob Agents Chemother 1991, 35: 615-21.
10. Lee, J., Allende, M., Amantea, M. et al. Pharmacokinetics and efficacy of amphotericin B lipid complex (ABLC) against chronic disseminated candidiasis in rabbits. 31st Intersci Conf Antimicrob Agents Chemother (Sept 29-Oct 2, Chicago) 1991, Abst 579.
11. Lee, J., Allende, M., Dollenberg, H. et al. Reticuloendothelial loading with amphotericin B lipid complex (ABLC) - A novel pharmacodynamic approach to the treatment of experimental hepatosplenic candidiasis. 32nd Intersci Conf Antimicrob Agents Chemother (Oct 11-14, Anaheim) 1992, Abst 172.
12. Perfect, J.R., Wright, K.A. Amphotericin B lipid complex in the treatment of experimental cryptococcal meningitis and disseminated candidosis. J Antimicrob Chemother 1994, 33: 73-81.
13. Olsen, S.J., Swerdel, M.R., Blue, B., Williams, S., Clark, J.M. Localized Candida infections in mice treated with amphotericin B lipid complex (ABLC) and putative mode of ABLC transport. 90th Gen Meet Amer Soc Microbiol (May 13-17, Anaheim) 1990, Abst A-111.
14. Whitney, R.R., Kunselman, L., Clark, J.M., Bonner, D.P. Efficacy of amphotericin B lipid complex (ABLC) in cryptococcal meningitis in normal and immunocompromised mice. 29th Intersci Conf Antimicrob Agents Chemother (Sept 17-20, Houston) 1989, Abst 166.
15. Data on file, The Liposome Company, Inc.
16. Clemons, K.V., Stevens, D.A. Comparative efficacies of amphotericin B lipid complex and amphotericin B deoxycholate suspension against murine blastomycosis. Antimicrob Agents Chemother 1991, 35: 2144-6.
17. Krawiec, D.R., McKiernan, B.C., Twardock, A.R., Swenson, C.E. Evaluation of the efficacy and nephrotoxicity of ABLC in spontaneous canine blastomycosis. Amer Coll Vet Intern Med Forum (Jan 7, Orlando) 1995, Abst.
18. Clemons, K.V., Stevens, D.A. Efficacies of amphotericin B lipid complex (ABLC) and conventional amphotericin B against murine coccidioidomycosis. J Antimicrob Chemother 1992, 30: 353-63.
19. Allendoerfer, R., Yates, R.R., Sun, S.H., Graybill, J.R. Comparison of amphotericin B lipid complex with amphotericin B and SCH 39304 in the treatment of marine coccidioidal meningitis. J Med Vet Mycol 1992, 30: 377-84.
20. Gangneux, J.P., Sulihan, A., Garin, Y-J.F., Derouin, F. Lipid formulations of amphotericin B in the treatment of experimental visceral leishmaniasis. 35th Intersci Conf Antimicrob Agents Chemother (Sept 17-20, San Francisco) 1995, Abst B58.
21. Olsen, S.J., Swerdel, M.R., Blue, B., Clark, J.M., Bonner, D.P. Tissue distribution of amphotericin B lipid complex in laboratory animals. J Pharm Pharmacol 1991, 43: 831-5.
22. Bodey, G.P., Vartivarian, S. Aspergillosis. Eur J Clin Microbiol Infect Dis 1989, 8: 413-37.
23. Calderone, R., Diamond, R., Senet, J-M., Warmington, J., Filler, S., Edwards, J.E. Host cell-fungal cell interactions. J Med Vet Mycol 1994, 32 (S1): 151-68.
24. 2 expression and inflammation: The relationship with associated disease states. J Lipid Mediators 1993, 8: 1-30.